Meridian Investment Counsel Inc. Sells 1,096 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Meridian Investment Counsel Inc. lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 18.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,775 shares of the company’s stock after selling 1,096 shares during the period. Meridian Investment Counsel Inc.’s holdings in GE HealthCare Technologies were worth $373,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in GEHC. Franklin Resources Inc. increased its stake in GE HealthCare Technologies by 1.7% in the 4th quarter. Franklin Resources Inc. now owns 67,536 shares of the company’s stock valued at $5,280,000 after buying an additional 1,105 shares during the last quarter. Family Legacy Inc. increased its position in shares of GE HealthCare Technologies by 8.7% during the fourth quarter. Family Legacy Inc. now owns 15,593 shares of the company’s stock valued at $1,345,000 after acquiring an additional 1,243 shares during the last quarter. B. Metzler seel. Sohn & Co. AG lifted its holdings in GE HealthCare Technologies by 47.7% during the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 21,967 shares of the company’s stock worth $1,717,000 after acquiring an additional 7,096 shares during the period. St. James Investment Company LLC purchased a new position in GE HealthCare Technologies in the fourth quarter worth $16,397,000. Finally, Wellington Management Group LLP increased its position in shares of GE HealthCare Technologies by 17.2% during the 4th quarter. Wellington Management Group LLP now owns 24,341 shares of the company’s stock valued at $1,903,000 after purchasing an additional 3,575 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC stock opened at $80.01 on Monday. The firm has a 50 day moving average of $86.70 and a 200-day moving average of $85.86. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $36.59 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. GE HealthCare Technologies’s payout ratio is currently 3.23%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of research analyst reports. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.